TRAVERE THERAPEUTICS, INC. Convertible Debt, Fair Value Disclosures
TRAVERE THERAPEUTICS, INC. (TVTX) had Convertible Debt, Fair Value Disclosures of $300.60 million as of 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:ConvertibleDebtFairValueDisclosures · last filed 2022-02-24
- 2021-12-31: Convertible Debt, Fair Value Disclosures $300.60M.
- 2021-09-30: Convertible Debt, Fair Value Disclosures $280.10M.
- 2021-06-30: Convertible Debt, Fair Value Disclosures $234.70M.
- 2021-03-31: Convertible Debt, Fair Value Disclosures $281.90M.
| Period end | Convertible Debt, Fair Value Disclosures |
|---|---|
| 2021-12-31 | $300.60M 10-K · filed 2022-02-24 |
| 2021-09-30 | $280.10M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $234.70M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $281.90M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $285.70M 10-K · filed 2021-03-01 |
| 2020-09-30 | $230.90M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $225.90M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $195.60M 10-Q · filed 2020-05-11 |
| 2018-06-30 | $74.00M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $63.40M 10-Q · filed 2018-07-06 |
| 2017-09-30 | $71.70M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $61.20M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $62.30M 10-Q · filed 2017-05-05 |
| 2016-09-30 | $74.70M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $67.30M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $59.80M 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |